Literature DB >> 8627325

Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes.

C Saura1, F Ciruela, V Casadó, E I Canela, J Mallol, C Lluis, R Franco.   

Abstract

Adenosine deaminase is an enzyme of purine metabolism that has largely been considered to be cytosolic. A few years ago, adenosine deaminase was reported to appear on the surface of cells. Recently, it has been demonstrated that adenosine deaminase interacts with a type II membrane protein known as either CD26 or dipeptidylpeptidase IV. In this study, by immunoprecipitation and affinity chromatography it is shown that adenosine deaminase and A1 adenosine receptors interact in pig brain cortical membranes. This is the first report in brain demonstrating an interaction between a degradative ectoenzyme and the receptor whose ligand is the enzyme substrate. By means of this interaction adenosine deaminase leads to the appearance of the high-affinity site of the receptor, which corresponds to the receptor-G protein complex. Thus, it seems that adenosine deaminase is necessary for coupling A1 adenosine receptors to heterotrimeric G proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627325     DOI: 10.1046/j.1471-4159.1996.66041675.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane.

Authors:  S Sarrió; V Casadó; M Escriche; F Ciruela; J Mallol; E I Canela; C Lluis; R Franco
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 2.  Partners for adenosine A1 receptors.

Authors:  Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.

Authors:  Rafael Franco
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

Review 4.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 5.  Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.

Authors:  R Franco; C Lluis; E I Canela; J Mallol; L Agnati; V Casadó; F Ciruela; S Ferré; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

Review 6.  A1 Adenosine Receptor Activation Modulates Central Nervous System Development and Repair.

Authors:  Shirin Kashfi; Kamran Ghaedi; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani; Mohammad Javan
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

7.  Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.

Authors:  Silvia Ginés; Marta Mariño; Josefa Mallol; Enric I Canela; Chikao Morimoto; Christian Callebaut; Ara Hovanessian; Vicent Casadó; Carmen Lluis; Rafael Franco
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

Review 8.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

Review 9.  Adenosine receptors and asthma in humans.

Authors:  C N Wilson
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.